• 2006

Company Description

MacuCLEAR focuses on discovering and developing novel solutions for vascular disorders of the eye.

MacuCLEAR Inc. is a specialty clinical-stage pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye. MacuCLEAR has an active IND for MC-1101 and has completed a novel and successful Phase Ib/POC human clinical trial.